Cleerly LABS vs KardiaPro
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if you need a detailed, non-invasive assessment of coronary artery disease (CAD) through AI-powered analysis of CCTA images. It is ideal for quantifying plaque volume, characterizing plaque types (e.g., high-risk vs. low-risk), detecting stenosis, and tracking disease progression over time to personalize heart disease management and prevention strategies.
View Cleerly LABS →Choose KardiaPro if…
Choose KardiaPro if you require a comprehensive, web-based platform for remote patient monitoring of various cardiac data, including ECGs, blood pressure, and weight. It is best suited for clinicians managing patients with known or suspected arrhythmias, hypertension, or heart failure, enabling efficient review of longitudinal cardiac patterns, automated arrhythmia detection, and informed clinical decision-making between appointments.
View KardiaPro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | KardiaPro |
|---|---|---|
| Pricing | Per analysis | Contact for pricing |
| Deployment | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. | Cloud-hosted, Web-based |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
KardiaProKardiaPro offers a comprehensive web-based portal with a dashboard for remote monitoring, trend visualization, and customizable ECG inbox for efficient data review, enhancing patient engagement with features like medication reminders. Cleerly LABS provides a rich diagnostic user experience for clinicians to review and interpret CCTA data with actionable insights, but its primary focus is on analysis rather than ongoing patient management and engagement.
Clinical Value
Cleerly LABSCleerly LABS provides comprehensive, AI-powered analysis of coronary CT angiography to detect, quantify, and characterize atherosclerosis and stenosis, with an ISCHEMIA module for ischemia detection, validated against invasive FFR. KardiaPro offers FDA-cleared AI for arrhythmia detection and remote monitoring of ECG, blood pressure, and weight data, which is valuable for managing chronic conditions, but Cleerly's detailed plaque analysis and ischemia detection offer a more profound diagnostic and prognostic clinical value for heart disease.
Pricing & Value
TieCleerly LABS has a retail price of $1500 per analysis, with a discounted rate of $750, plus the separate cost of a CCTA scan (totaling $1000-$1500 out-of-pocket), and growing insurance coverage. KardiaPro requires contacting AliveCor for pricing, but states it is reimbursable using existing CPT codes and has been deemed cost-effective in some assessments. Without direct comparable pricing for KardiaPro's full suite of services, it's difficult to definitively declare a winner in terms of overall value.
Enterprise Readiness
KardiaProKardiaPro is a comprehensive web-based portal designed for remote patient monitoring, offering seamless integration with KardiaMobile devices, KardiaStation for point-of-care solutions, and EHR/third-party interoperability with SDK/API configurations. Cleerly LABS is cloud-based with an on-site proxy for data transfer and integration with PACS, RIS, and EHR, but KardiaPro's focus on scalable remote monitoring and broader integration options for various data types gives it an edge in enterprise readiness.
Innovation
Cleerly LABSCleerly LABS utilizes AI for comprehensive quantitative analysis of CCTA images to characterize plaque volume, type, and stenosis, and detect ischemia, offering a novel approach to personalized heart disease management and risk assessment. While KardiaPro employs FDA-cleared AI for arrhythmia detection and remote monitoring, Cleerly's detailed and quantitative assessment of atherosclerosis from imaging data represents a more significant innovation in cardiac diagnostics.
Support & Docs
TieBoth tools offer support and documentation. KardiaPro provides user guides and FAQs, with phone and email support. Cleerly offers client support Monday through Friday, 10 am to 6 pm ET, and aims for timely responses. Without more detailed information on the breadth and depth of their documentation or specific user satisfaction with support, it's a tie.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | KardiaPro |
|---|---|---|
| Tool Name | Cleerly LABS | KardiaPro |
| Company | Cleerly | AliveCor |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | A comprehensive web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection and other cardiac determinations. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Clinical Decision Support & Reference, Wearables & Remote Monitoring (RPM) |
| Key Features (Primary Focus) | AI-powered CCTA image analysis, comprehensive coronary plaque assessment, stenosis detection and quantification. | Remote monitoring of ECG, blood pressure, and weight data, FDA-cleared AI for arrhythmia detection. |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and KardiaPro.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or KardiaPro
Backers
Who funded each tool's parent company.